ARCHIVES

IOM To Form Committee To Investigate Duke Genomics Research

This article is from The Cancer Letter archive.

Vol. 36 No. 35 | October 1, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

Harkin, Hatfield Propose Cigarette Tax To Fund NIH Research

September 22, 1995

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003